GWS
ICPT

Glassman Wealth Services’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Glassman Wealth Services’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-13
Closed – – 2030
2021
Q4 		$0 Buy
+13
New +$219 ﹤0.01% 1993
2020
Q3 		– Sell
-4
Closed – – 1546
2020
Q2 		$0 Sell
4
-100
-96% -$7.72K ﹤0.01% 1613
2020
Q1 		$7K Buy
104
+4
+4% +$359 ﹤0.01% 488
2019
Q4 		$12K Buy
+100
New +$8.95K ﹤0.01% 457
2019
Q3 		– Sell
-11
Closed -$1K – 1452
2019
Q2 		$1K Hold
11
– – ﹤0.01% 977
2019
Q1 		$1K Buy
+11
New +$1.2K ﹤0.01% 942
2018
Q1 		– Sell
-4
Closed – – 957
2017
Q4 		$0 Buy
+4
New +$252 ﹤0.01% 822

Other funds holding ICPT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Glassman Wealth Services's ICPT Position: Q1 2022 in Review

Glassman Wealth Services sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2022, closing a stake of 13 shares.

Glassman Wealth Services first reported a position in ICPT in Q4 2017 and held it in 7 quarters. The position peaked at $12K in Q4 2019. 148 funds tracked by Wall St. Rank hold ICPT as of Q1 2022.

  • Glassman Wealth Services reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
  • Glassman Wealth Services sold 13 Intercept Pharmaceuticals, Inc. shares in Q1 2022.
  • Glassman Wealth Services first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2017 and held it in 7 quarters.
  • Glassman Wealth Services's Intercept Pharmaceuticals, Inc. position peaked at $12K in Q4 2019.
  • 148 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2022.

Based on Glassman Wealth Services's 13F filing for Q1 2022, filed 14 Apr 2022.